Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology-enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was incorporated in 2003 and is headquartered in Henderson, Nevada.
Ontrak Stock Performance
Ontrak stock opened at $0.80 on Wednesday. The company has a market cap of $20.84 million, a price-to-earnings ratio of -0.24 and a beta of 2.26. The company has a debt-to-equity ratio of 0.31, a current ratio of 2.72 and a quick ratio of 2.72. Ontrak has a 12 month low of $0.60 and a 12 month high of $22.44. The stock's 50-day moving average is $1.09 and its 200-day moving average is $1.71.
Analyst Ratings Changes
OTRK has been the topic of a number of research reports. Cowen cut their price objective on Ontrak from $9.00 to $1.30 in a report on Tuesday, May 17th. Benchmark cut their price objective on Ontrak from $4.00 to $3.00 in a report on Thursday, August 11th.
Insider Activity at Ontrak
In related news, insider Arik Hill bought 26,315 shares of the company's stock in a transaction that occurred on Friday, May 20th. The shares were acquired at an average cost of $1.52 per share, for a total transaction of $39,998.80. Following the acquisition, the insider now owns 26,315 shares in the company, valued at approximately $39,998.80. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 46.60% of the company's stock.